Viewing Study NCT05489458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-05-25 @ 12:31 AM
Study NCT ID: NCT05489458
Status: UNKNOWN
Last Update Posted: 2022-08-05
First Post: 2022-08-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Predictive Factors for Resection and Survival in Type A Borderline Resectable Pancreatic Ductal Adenocarcinoma Patients After Neoadjuvant Therapy
Sponsor: BUSQUETS, JULI
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Pancreatic Ductal View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BR-PDAC View
None Pancreatic Ductal Adenocarcinoma View
None Borderline Resectable View
None CA 19-9 View
None Anatomical View